Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PARITY prophylactic antibiotic regimens in tumor surgery
2013-004447-23Phase 4Terminated
- Sponsor
- Taysha Gene Therapies
- Start
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of cefuroxime in surgical site infection (SSI) (2 arms), sponsored by Taysha Gene Therapies. Primary endpoint: Deep surgical site infection within 12 months. Started Feb 2014; status: terminated.
02
Drugs
cefuroxime
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on 2013-004447-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004447-23.